Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 382Leukemia, Myeloid, Acute 356Precursor Cell Lymphoblastic Leukemia-Lymphoma 184Leukemia 149Leukemia, Myelogenous, Chronic, BCR-ABL Positive 147Leukemia, Myelomonocytic, Chronic 128Myeloproliferative Disorders 114Leukemia, Lymphocytic, Chronic, B-Cell 100Primary Myelofibrosis 99Multiple Myeloma 89Lymphoma, Non-Hodgkin 89Hodgkin Disease 76Blast Crisis 68Lymphoma 62Leukemia, Myeloid, Chronic-Phase 58Lymphoma, Large B-Cell, Diffuse 53Lymphoma, Mantle-Cell 52Lymphoma, Follicular 52Burkitt Lymphoma 52Hematologic Neoplasms 51Leukemia, Myeloid, Accelerated Phase 50Congenital Abnormalities 47Polycythemia Vera 45Lymphoma, B-Cell, Marginal Zone 44Thrombocythemia, Essential 43Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 42Myelodysplastic-Myeloproliferative Diseases 41Neoplasms, Plasma Cell 40Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 40

Interventions

quizartinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Aortic aneurysm, familial thoracic 4 × Myeloid × Clear all
NCT00462761 2020-05-11

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

Daiichi Sankyo

Phase 1 Completed
76 enrolled 12 charts
MyeloidOther hematologic neoplasm

Aortic aneurysm, familial thoracic 4, Leukemia, Erythroblastic, Acute, Leukemia, Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡